Page last updated: 2024-08-23

cromolyn sodium and Cryptogenic Fibrosing Alveolitis

cromolyn sodium has been researched along with Cryptogenic Fibrosing Alveolitis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agrawal, S; Birring, SS; Maher, TM; Morice, AH; Stone, H; Tutuncu, A; van den Berg, JWK; Wijsenbeek, MS1

Trials

1 trial(s) available for cromolyn sodium and Cryptogenic Fibrosing Alveolitis

ArticleYear
A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial.
    The Lancet. Respiratory medicine, 2017, Volume: 5, Issue:10

    Topics: Administration, Inhalation; Adult; Aged; Anti-Asthmatic Agents; Chronic Disease; Cough; Cromolyn Sodium; Cross-Over Studies; Double-Blind Method; Female; Humans; Idiopathic Pulmonary Fibrosis; Lung; Male; Middle Aged; Nebulizers and Vaporizers; Netherlands; Pilot Projects; Proof of Concept Study; Treatment Outcome; United Kingdom; Young Adult

2017